Ophthalmic Drug Isopto Atropine Recalled Due to Manufacturing Temperature Deviation
McKesson Medical-Surgical is recalling 13 bottles of Isopto Atropine 1% ophthalmic solution due to temperature-abuse violations of manufacturing standards that may have affected product sterility.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with manufacturing quality deviations but no reported illnesses or injuries. Temperature abuse of a sterile pharmaceutical product presents potential quality and sterility risk without confirmed adverse events, fitting the High severity criterion for risk-of-harm products without reported injury.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Isopto Atropine (atropine sulfate ophthalmic solution) 1%, 5mL bottles (NDC 0065-0303-55), manufactured by Alcon Surgical. The recall encompasses 13 bottles distributed nationwide to healthcare providers and facilities.
The recall was initiated due to current Good Manufacturing Practice (cGMP) deviations involving temperature abuse during manufacturing. These deviations may have affected the sterility and efficacy of the recalled product.
Healthcare providers and pharmacies that received affected bottles should discontinue use immediately. Because the manufacturer could not identify specific lot numbers for individual recipients, providers should refer to distribution dates in their recall notification letters. Patients currently using this product should consult their healthcare provider for guidance and alternative treatments.
The recalled product
- Product
- ISOPTO ATROPINE (ATROPINE SULFATE)
- Brand
- ISOPTO ATROPINE
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Ophthalmic / Eye Drops
- Hazard
- temperature-abuse
- manufacturing-defect
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27